Stage III Adrenal Cortical Carcinoma AJCC v8
1 clinical trials · Condition
◉ Watch Stage III Adrenal Cortical Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer (NCT06900595) | National Cancer Institute (NCI) | 2026-02-22 |
Track Stage III Adrenal Cortical Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.